For IHC-P: Use at a concentration of 4 - 6μg/ml. For WB: Use at a concentration of 0.5 - 1μg/ml. Predicted molecular weight: 46 kDa. Optimal dilutions/concentrations should be determined by the researcher.
VEGF recognizes VEGF121, VEGF165, VEGF189, and VEGF206.
50 mM sodium phosphate buffer, 0.2% gelatin, pH 7.5 with =0.1% sodium azide
Store as concentrated solution. Centrifuge briefly prior to opening vial. Store at 4ºC. DO NOT FREEZE.
0.1 mg/ml (Please refer to the vial label for the specific concentration.)
Synthetic peptide (Human) (N terminal) of VEGF165.
For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
VEGFA, VPF, 125853, 7422, P15692, MGC70609, VEGF
VEGF (Vascular Endothelial Growth Factor) is a homodimeric, disulfide-linked glycoprotein involved in angiogenesis which promotes tumor progression and metastasis. It exhibits potent mitogenic and permeability inducing properties specific for the vascular endothelium. Of the four isoforms of VEGF, the smaller two, VEGF 165 and VEGF 121, are secreted proteins and act as diffusible agents, whereas the larger two (VEGF 189 and VEGF 206) remain cell associated.